|1.||D'Alessio, Giuseppe: 1 article (06/2008)|
|2.||De Lorenzo, Claudia: 1 article (06/2008)|
|3.||Riccio, Gennaro: 1 article (06/2008)|
|4.||Borriello, Marianna: 1 article (06/2008)|
|5.||De Lorenzo, C: 1 article (11/2007)|
|6.||Troise, F: 1 article (11/2007)|
|7.||D'Alessio, G: 1 article (11/2007)|
|8.||Cafaro, V: 1 article (11/2007)|
06/01/2008 - "This novel immunoagent with 2 scFv moieties each fused to 1 of the 2 subunits of the dimeric RNase, called ERB-HHP2-RNase, has shown improved biologic properties with respect to the previously reported monomeric ERB-hRNase immunoRNase: it selectively binds ErbB2-positive cancer cells with an increased avidity; it is not inhibited by the cytosolic ribonuclease inhibitor; it is endowed with a more powerful cytotoxic activity."
11/19/2007 - "Two anti-ErbB2 immunoconjugates, called Erb-hRNase and Erb-hcAb, have been prepared and found to be selectively cytotoxic on ErbB2-positive cancer cells in vitro and vivo. "
|2.||Breast Neoplasms (Breast Cancer)
|3.||Immunoglobulin G (IgG)